KRAFTON India has announced its investment in Shuru, a fast-growing hyperlocal community app delivering local updates connecting users across India. The Series A funding round led by KRAFTON India ...

Boomi Recognized as a Leader for the 11th Time in the 2025 Gartner® Magic Quadrant™ for Integration Platform as a Service ...

Network flow data, in the form of IPFIX records, is essential for understanding network traffic, detecting anomalies, and ensuring optimized performance and robust security. The new alliance leverages ...

Novotech a globally recognized full-service clinical research organization (CRO) and scientific ... This press release ...

Freo recently acquired its corporate agency license from IRDAI, and now has launched a full-fledged initiative to make health insurance simple, clear, and stress-free—so people can make smarter ...

WNS (Holdings) Limited (NYSE: WNS), a digital-led business transformation and services company, today announced that WNS Procurement has been recognized for the fifth consecutive year as a ‘Leader’ in ...

A man shocked everyone by eating a red envelope that had just been handed to him. This adds another twist to the growing mystery around the so-called "Red Envelope Society." According to witnesses, ...

SDA Bocconi Asia Center, Mumbai Invites Applications for Its Landmark 10th Cohort of the International Executive Master in Business ...

CCM Biosciences, a diversified pharmaceutical discovery and development company, today announced the upcoming presentation of its next-generation FLT3 inhibitor drug program for acute myeloid leukemia ...

Aptos Foundation, dedicated to supporting the development and ecosystem of the high-performance Aptos blockchain, and Hashed Emergent, a Web3 venture capital firm, have announced today a strategic ...

Visa (NYSE:V), a global leader in digital payments, announced Visa Commercial Integrated Partners, a new program designed to improve connectivity between fintechs and Visa Commercial products through ...

CCM Biosciences, a diversified pharmaceutical discovery and development company, today announced the upcoming presentation of its 4th-generation EGFR inhibitor drug program for non-small cell lung ...